Search
Regeneron Pharmaceuticals Inc
REGNAdd to Watchlist
607.730USD
-7.000-1.14%
Close 06/17, 16:00（ET）Quotes delayed by 15 min
63.73BMarket Cap
14.31P/E TTM
Financial Health
Currency: USD Updated: 2026-06-17 The current financial score of Regeneron Pharmaceuticals Inc is 9.28, ranking 4 out of 157 in the Pharmaceuticals industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 3.61B, representing a year-over-year increase of 19.04%, while its net profit experienced a year-over-year increase of 10.08%.
Financials
7.87
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.77
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
10.00
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
10.00
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
9.78
Free cash flow
Relevant data have not been disclosed by the company yet.
